Literature DB >> 12804922

The ajmaline challenge in Brugada syndrome: a useful tool or misleading information?

J Brugada, P Brugada, R Brugada.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12804922     DOI： 10.1016/s0195-668x(03)00232-x

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  5 in total

1.  Risk Stratification and Therapeutic Approach in Brugada Syndrome.

Authors:  Vincent Probst; Stéphanie Chatel; Jean-Baptiste Gourraud; Hervé Le Marec
Journal:  Arrhythm Electrophysiol Rev       Date:  2012-09

2.  Ajmaline blocks INa and IKr without eliciting differences between Brugada syndrome patient and control human pluripotent stem cell-derived cardiac clusters.

Authors:  Duncan C Miller; Stephen C Harmer; Ariel Poliandri; Muriel Nobles; Elizabeth C Edwards; James S Ware; Tyson V Sharp; Tristan R McKay; Leo Dunkel; Pier D Lambiase; Andrew Tinker
Journal:  Stem Cell Res       Date:  2017-11-07       Impact factor: 2.020

3.  Novel SCN5A p.W697X Nonsense Mutation Segregation in a Family with Brugada Syndrome.

Authors:  Emanuele Micaglio; Michelle M Monasky; Nicoletta Resta; Rosanna Bagnulo; Giuseppe Ciconte; Luigi Gianelli; Emanuela T Locati; Gabriele Vicedomini; Valeria Borrelli; Andrea Ghiroldi; Luigi Anastasia; Sara Benedetti; Chiara Di Resta; Maurizio Ferrari; Carlo Pappone
Journal:  Int J Mol Sci       Date:  2019-10-04       Impact factor: 5.923

Review 4.  Severe cholestatic jaundice after a single administration of ajmaline; a case report and review of the literature.

Authors:  Benjamin H Mullish; Rishi K Fofaria; Belinda C Smith; Kirsty Lloyd; Josephine Lloyd; Robert D Goldin; Ameet Dhar
Journal:  BMC Gastroenterol       Date:  2014-04-02       Impact factor: 3.067

5.  Torsades de pointes induced by concomitant use of chlorpheniramine and propranolol: An unusual presentation with no QT prolongation.

Authors:  Altuğ Ösken; Nizamettin Selçuk Yelgeç; Regayip Zehir; Tuğba Kemaloğlu Öz; Selçuk Yaylacı; Ramazan Akdemir; Hüseyin Gündüz
Journal:  Indian J Pharmacol       Date:  2016 Jul-Aug       Impact factor: 1.200
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.